Zheng, Z.; Xu, Y.; Krügel, U.; Schaefer, M.; Grune, T.; Nürnberg, B.; Köhler, M.-B.; Gollasch, M.; Tsvetkov, D.; Markó, L.
In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome. Int. J. Mol. Sci. 2022, 23, 6870.
https://doi.org/10.3390/ijms23126870
AMA Style
Zheng Z, Xu Y, Krügel U, Schaefer M, Grune T, Nürnberg B, Köhler M-B, Gollasch M, Tsvetkov D, Markó L.
In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome. International Journal of Molecular Sciences. 2022; 23(12):6870.
https://doi.org/10.3390/ijms23126870
Chicago/Turabian Style
Zheng, Zhihuang, Yao Xu, Ute Krügel, Michael Schaefer, Tilman Grune, Bernd Nürnberg, May-Britt Köhler, Maik Gollasch, Dmitry Tsvetkov, and Lajos Markó.
2022. "In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome" International Journal of Molecular Sciences 23, no. 12: 6870.
https://doi.org/10.3390/ijms23126870
APA Style
Zheng, Z., Xu, Y., Krügel, U., Schaefer, M., Grune, T., Nürnberg, B., Köhler, M. -B., Gollasch, M., Tsvetkov, D., & Markó, L.
(2022). In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome. International Journal of Molecular Sciences, 23(12), 6870.
https://doi.org/10.3390/ijms23126870